IRMD — Iradimed Co
NASDAQ · Healthcare · Medical Devices
$87.00
+$0.62 (+0.72%)
Iradimed Co (IRMD) is a medical devices company listed on NASDAQ. It is led by Roger E. Susi, based in 12705 Ingenuity Drive, Orlando, FL, United States, 32826, with about 166 employees. IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors in the United States and internationally. The company was incorporated in 1992 and is headquartered in Orlando, Florida.
Latest reported IRMD revenue for 2025-09-30 was $21.2M. Net income was $16.0M. Revenue was up 3.9% from 2025-06-30 to 2025-09-30. IRMD currently screens at market cap $1.19B and trailing P/E 50.9.
Use this IRMD page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the IRMD quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the IRMD SEC filings page. Lician reads the product cache first so this HTML stays unique to Iradimed Co even when a live quote feed is slow.
About Iradimed Co
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors in the United States and internationally. The company was incorporated in 1992 and is headquartered in Orlando, Florida.
IRMD Key Statistics
Market Cap
$1.19B
Volume
45,558
Previous Close
$87.18
Day Range
$85.73 – $88.87
P/E Ratio
50.86
EPS
$1.50
Revenue
$73.24M
Net Income
$19.23M
Gross Profit
$0.00
Free Cash Flow
$0.00
Dividend Yield
0.79%
Revenue Growth
+11.7%
Profit Margin
26.3%
Employees
166
IRMD Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $73.24M | $65.56M | $53.30M | $41.81M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | $19.23M | $17.19M | $12.83M | $9.33M |
| EPS (Diluted) | $1.50 | $1.35 | $1.02 | $0.74 |
Total Assets
$98.33M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$52.23M
Operating Cash Flow
$25.62M
Free Cash Flow
$0.00
Iradimed Co Company Information
- Founder, Chairman, CEO & President
- Roger E. Susi
- Headquarters
- 12705 Ingenuity Drive, Orlando, FL, United States, 32826
- Website
- www.iradimed.com
- Phone
- 407 677-8022
- IPO / Founded
- 2014-07-16
- Sector
- Healthcare
- Industry
- Medical Devices